Telemedicine during the COVID‐19 epidemic improves outcomes in children with tuberous sclerosis complex: A 1206 visits retrospective cohort study

Author:

Wang Xia1,Wang Ji2ORCID,Du Xiaonan2,Yu Lifei2,Zhou Yuanfeng2,Zhou Shuizhen2,Wang Yi2,Ding Yifeng2ORCID

Affiliation:

1. Department of Neonatology Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine Shanghai China

2. Department of Neurology, National Children Medical Center Children's Hospital of Fudan University Shanghai China

Abstract

AbstractAimsTo evaluate the benefits of telemedicine in children with tuberous sclerosis complex during the COVID‐19 pandemic.MethodsA retrospective cohort study was conducted, comparing telemedicine and in‐person visits within the timeframe spanning from June 1, 2021, to June 1, 2022. Disparities in demographics, emergency visits, hospitalizations, adverse effects (AEs) associated with sirolimus, and the incidence of drug‐refractory epilepsy (DRE) between telehealth and in‐person care were assessed. Additionally, distinctions between audio and video telehealth, as well as varying frequencies of telehealth encounters, were investigated and reported as odds ratios (ORs).ResultsA total of 378 patients with 1206 visits were included, of which 137 were telemedicine patients and 241 were in‐person patients. The median age was 5.0 years (IQR 2.8–10.0 years). There were 197 males (52.12%), 691 in‐person visits (57.30%), and 515 telemedicine visits (42.70%). Children under 12 years old, those farther away from the center, mothers with more than 12 years of education, and children treated with sirolimus were more likely to visit via telemedicine. Telehealth was associated with significantly fewer emergency visits, hospitalizations, AEs of sirolimus, and DRE. With 10 or more visits, the incidence of emergency visits, hospitalization, and DRE was significantly reduced.ConclusionTelemedicine visits are almost as close in number as in‐person visits. Younger patients, patients in remote areas, and mothers with higher education levels are more willing to complete telemedicine visits. Telemedicine visits were associated with a significantly lower number of emergency visits, hospitalizations, and AEs of sirolimus. Patients with more than 10 visits per year seemed to have better clinical outcomes.

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Pharmacology (medical),Physiology (medical),Psychiatry and Mental health,Pharmacology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3